← Leaderboards
Leomar Y Ballester
University Of Texas Hlth Sci Ctr Houston
$1,269,369
Attributed
$1,269,369
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $260.6K · FY2020–24$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,269,369 · 1
By mechanism
K08$1,269,369 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Hlth Sci Ctr Houston
Same institution · by research overlap
- Jaroslaw A. Aronowski$13,611,686
- Sunil Krishnan$6,566,279
- Sang Hyun Cho$5,825,687
- Kyoji Tsuchikama$3,574,789
- Bharti Manwani$3,508,353
Others in their field
Other Emerging Leaders on “Affect”
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$62,378,387
- Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,788,199
- George Robert Painter · University Of Alabama At Birmingham$27,619,145
- Jessica Brooke Langbaum · Banner Health$22,633,312
Research focus
AffectAssay DevelopmentBiological MarkersBiopsyBloodBrain NeoplasmsBrain ParenchymaBrain SurgeryCancer CellCancer TypeCentral Nervous System NeoplasmsCerebrospinal FluidClinical ImplementationClinical PracticeCollectionDetectionDiagnosisDigitalEffective TherapyExperimental StudyGene FrequencyGenesGliomaAdult
Grant awards (6)
Development and Validation of a CSF Liquid Biopsy for Molecular Characterization and Monitoring of Patients with Central Nervous System Tumors$260,634
K08 · FY2024 · CA · contact PI
Development and Validation of a CSF Liquid Biopsy for Molecular Characterization and Monitoring of Patients with Central Nervous System Tumors$260,634
K08 · FY2023 · CA · contact PI
Development and Validation of a CSF Liquid Biopsy for Molecular Characterization and Monitoring of Patients with Central Nervous System Tumors$260,634
K08 · FY2022 · CA · contact PI
Development and Validation of a CSF Liquid Biopsy for Molecular Characterization and Monitoring of Patients with Central Nervous System Tumors$243,755
K08 · FY2021 · CA · contact PI
Development and Validation of a CSF Liquid Biopsy for Molecular Characterization and Monitoring of Patients with Central Nervous System Tumors$1
K08 · FY2021 · CA · contact PI
Development and Validation of a CSF Liquid Biopsy for Molecular Characterization and Monitoring of Patients with Central Nervous System Tumors$243,711
K08 · FY2020 · CA · contact PI